throbber
q
`
`rn , -r-rn ,
`
`~
`
`ta >
`N
`r
`•
`n
`:I:
`0 :z
`• .,
`
`C)
`
`::tl
`IT1
`[]
`~
`
`l> :z
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 1/216
`
`

`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 2/216
`
`

`
`Epilepsy
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 3/216
`
`

`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 4/216
`
`

`
`Epilepsy
`
`Carl W. Bazll, MD, PhD
`Caitlin Tynan Doyle Professor of Clinical Neurology
`Director, Division of Epilepsy and Sleep
`Columbia University Department of Neurology
`New York, NY
`
`Derek J. Chong, MD
`Assistant Professor of Clinical Neurology
`Director, ~linical Trials in Epilepsy & Sleep
`Columbia University Department of Neurology
`New York, NY
`
`Daniel Friedman, MD
`Assistant Professor of Neurology
`Depanment of Neurology
`New York University School of Medicine
`New York, NY
`
`OXFORD
`
`UNIVERSITY PRESS
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 5/216
`
`

`
`I I
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 6/216
`
`

`
`To our patients, who have taught us the most about epilepsy, and that
`a life with epilepsy can be every bit as full as life without it.
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 7/216
`
`

`
`Preface
`
`Epilepsy is a diverse and sometimes complicated condition. It is also very
`common, such that all neurologists, and nearly all physicians, will encoun"
`ter patients with epilepsy. Perhaps more than most other conditions in neu(cid:173)
`rology, epilepsy is further complicated by potential interactions with other
`medical conditions and with a patient's lifestyle.
`This volume contains numerous case examples, meant to Ulustrate sce(cid:173)
`narios that commonly arise in the clinical care of patients with epilepsy and
`ways of approaching them. The first section has chapters that address diag(cid:173)
`nostic questions: How to approach a first seizure? What about diagnostic
`challenges, such as confusion with syncope or parasomnias? Drug therapy
`is indicated for nearly all patients with epilepsy, so the second section con(cid:173)
`tains various scenarios dealing with anticonvulsant drugs, including choos(cid:173)
`ing from the large number of drugs available in each epilepsy syndrome,
`choosing drugs in specific patient populations, drug interactions, and when
`(if ever) it may be appropriate to withdraw anticonvulsant treatment in a
`patient with epilepsy. If drug therapy is not completely effective or is other(cid:173)
`wise unsatisfactory, alternatives are discussed in the third section. Finally,
`the fourth section looks at lifestyle and other issues: the mood and cognitive
`disorders so prevalent in epilepsy, the topic of sudden death in epilepsy,
`issues of bone health and sleep disorders, and implications for driving
`and work.
`Each epilepsy patient is different-these are only a few examples. But we
`hope you will find this volume useful in thinking about the problems you
`encounter in treating people with epilepsy.
`
`vll
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 8/216
`
`

`
`n
`
`Contents
`
`SECTION I DIAGNOSTIC QUESTIONS
`
`1
`
`Febrile Seizures and Other Seizures In Infants 3
`Daniel Friedman
`Febrile seizures are common and are often benign, with little risk of subsequent
`epilepsy. However, febrtle seizures with complex features may increase the risk of
`eptlepsy later in life or may be the heralding seizure of a severe infantile eptlepsy
`syndrome.
`
`2 Benign/Idiopathic Partial Epilepsies (IPE) of Childhood 8
`Derek j. Cbong
`Benign rolandic eptlepsy {BECfS) and the benign occipital eptlepsies have
`specific clinical features and electrographic findings that set them apart from
`other types of eptlepsy. 1he diagnosis of these conditions is imponant as they
`impart a high chance of spontaneous and complete remission.
`
`3 Nonconvulslve Seizures In Acutely 111 Patients 16
`Daniel Friedman
`Seizures without overt convulsive activity are common in critically ill and acute
`brain injury patients. Often the only manifestation is altered mental status, and
`EEG monitoring is required for the diagnosis. Treatment is aimed at controlling
`seizures co limit secondary neuronal injury whtle minimizing the adverse effects
`of therapy.
`-
`
`4 Psychogenic Noneplleptlc 'Seizures 25
`Carl w. Bazil
`About 25% of patients with refractory eptlepsy who are referred to epilepsy
`centers actually are found to have psychogenic noneptleptic seizures. These can be
`very confusing to treating clinicians, as by history they may sound exactly like
`epUeptic s~izures. Correct diagnosis usually requires video~EEG monitoring, and
`diagnosis is critical in redirecting appropriate care for the patient.
`
`5
`
`Frontal Lobe Seizures 32
`Daniel Friedman
`Seizures of frontal lobe origin often have little EEG correlate and can have bizarre
`semiologies that can be p1istaken for nonepileptic seizures. Nocturnal onsets and
`stereotyped features are clues to the diagnosis.
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 9/216
`
`

`
`6
`
`7
`
`Seizure Versus Parasomnlas 37
`Carl W. Bazil
`Paroxysmal episodes that occur during sleep can be a diagnostic dilemma. History
`may be imperfect or even nonexistent, as patients may not recall the actual
`episode, and witnesses may not be present. Careful history may be able to
`distinguish whether the event is a seizure or a parasomnia, but diagnostic testing
`withpolysomnography and/or video-EEG may-be required to confirm the
`diagnosis.
`
`Seizure Versus Syncope 46
`Carl w. Bazil
`Sudden loss of awareness could represent syncope or seizure. History is usually
`helpful in making the diagnosis, as characteristics such as tongue biting,
`incontinence, and postictal confusion are more suggestive of seizure.
`
`SECTION II TREATMENT CONSIDERATIONS: AEDs
`
`S
`
`9
`
`10
`
`First Unprovoked Seizure 53
`Derek]. Chong
`Up to 10% of the population will have a seizure in their lifetime, yet only 1% of
`the population will have recurrent, unprovoked seizures. The first recognized
`seizure is a frightening occurrence for patients. Standard of care includes an EEG
`and MRI of the head for prognostication of recurrence and to rule out
`symptomatic causes.
`
`Initial Treatment of Idiopathic Generalized Epilepsy 57
`Derek]. Chong
`Patients with idiopathic (or primary) generalized epilepsies are presumed to have
`a low threshold for seizures that may be of genetic origin. These syndromes
`represent 20% of all epilepsy cases. Treatment consists of broad-spectrum agents,
`with some specific medications used for specilic seizure types seen in IGE.
`
`lnltlal Treatment of Localization-Related Epilepsy 66
`Derek]. Chong
`There are over a dozen medications avallable to reduce the risk of panial onset
`seizures. The current motto of "no seizures, no side effects .. requires tailoring the
`choice of medication based on its characteristics and side-effect profile with the
`patient's own priorities. Mood and weight change are among the issues that are
`often important to patients.
`
`:11
`
`CONTENTS
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 10/216
`
`

`
`11 Status Eplleptlcus 71
`Daniel Friedman
`Generalized status epilepticus is a neurologic emergency associated with
`significant morbidity and monality. Prompt diagnosis and treatment; often
`guided by EEG monitoring, is necessary.
`
`12: Adverse Effects of AEDs-Rash 77
`Daniel Friedman
`Skin eruptions are commori rea~ions to AEDs and can rarely be serious and even
`life-threatening, with systemic manifestations. The key to treatment is usually
`discontinuing the offending drug without placing the patient at risk for seizures.
`
`13 Adverse Effects of AEDs-ldlosyncratlc Reactions 82
`Daniel Friedman
`AEDs can have rare hut serious effects that cannot he predicted by their
`mechanisms of action or metabolic pathways. These reactions can include hepatic
`dysfunction, hematologic abnormalities, pancreatitis, and CNS dysfunction.
`
`14 Generic AED Substitutions 88
`Carl w. Bazil
`Patients and insurers often inquire about lower-cost generic alternatives. While
`these may be appropriate for many patients, in epilepsy the additional variability
`introduced when using a generic equivalent requires more vigilance than in most
`other conditions.
`
`15 Withdrawal of AEDs 92
`Carl w. Bazil
`When a patient's seizures have been controlled for many years, it is often
`appropriate to ask whether anticonvulsant treatment may ~ly been withdrawn.
`There are many considerations here, and each patient's concerns and preferences,
`including risk aversion, must be taken into account before a recommendation can
`·be made:
`
`16 AED Failures 97
`Derek]. Chong
`Seizures may continue ro occur with medical treatment or the treatment may
`cause intolerable side effects; both are considered failures. The main choice to
`consider is substitution with another agent in monotherapy versus dual therapy.
`
`17 Drug-Drug Interactions: AEDs 102
`Derek]. Chong
`Many AEDs have effects on each other due to changes in liver enzymes and
`protein binding, particularly those of the older generation. Pharmacodynamic
`effects, including interactions at the level of the receptor, can be important in
`neurotoxic side effects and may play a role in polytherapy efficacy as well.
`
`CONTENTS
`
`xl
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 11/216
`
`

`
`18 Drug-Drug Interactions: Other Medications 108
`Derek]. Chong
`Enzyme-inducing medications include phenytoin, carbamazepine, phenobarbital,
`and to a lesser extent oxcarbazepine and topiramate. Significant interactions occur
`with medications that are often used concomitantly, such as oral contraceptives
`and warfarin.
`
`19 AEDs In Pregnancy and Lactation 112
`Daniel Friedman
`AEDs pose particular difficulties in pregnant women, including teratogenicity
`and altered metabolism. Many drugs are also excreted in breast milk, though
`most women wi~ epilepsy are able to breast-feed successfully.
`
`20 Treatment of Epilepsy In the Elderly 118
`Derek]. Chong
`Single and recurrent seizures are common in the dderly population. Acute
`symptomatic seizures are less likely to turn into epilepsy and long-tenn treatment
`is often not indicated. In other situations, treatment is important to reduce the
`sequdae of seizures, which could cause significant injury. Tolerability is the most
`important consideration, as many AEDs have the potential ro worsen other
`medical issues that are common in the elderly.
`
`SECTION Ill REFRACTORY EPILEPSY: DIAGNOSIS &
`MANAGEMENT ISSUES, INC"LUDING SURGERY AND
`ALTERNATIVE THERAPIES
`
`21 Refractory Epilepsy: General Approach 127
`Carl W. Bazil
`Patients with epilepsy who have failed two trials of an appropriate anticonvulsant
`drug should be considered for further evaluation. Usually, this includes video(cid:173)
`EEG monitoring to confinn the diagnosis, as a substantial subset will be found to
`have conditions other than epilepsy. If epilepsy is confirmed, the patient may be
`considered for other treatments, including alternative medications, devices, and
`surgery.
`
`22 Refractory Idiopathic Generalized Epilepsy 135
`Daniel Friedman
`Parients with idiopathic generalized epilepsy who continue to have seizures
`despite appropriate AEDs should undergo a trial of valproate, which may be the
`most effective agent in these epilepsies. Video-EEG monitoring. is recommended
`for patients with continued seizures as careful analysis may reveal a focal epilepsy .
`
`.11.1!
`
`CONTENTS
`
`I
`
`·u
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 12/216
`
`

`
`23 Refractory Localization-Related Epilepsy: Extratemporal Epilepsy and
`Intracranial EEG Recording 139
`Carl w. Bazil
`In refractory patients who have extratemporal onsets, surgical treatment is often
`more compllcated. These patients still have a higher chance of cure with surgery
`than with additional medication trials. In addition ro routine video-EEG
`monitoring and MRI, further imaging stUdies such as PET or SPECT scans may
`help ro localize onset. Intracranial electrode implantation followed by video--EEG
`monitoring is often required to definitively localize seizure onset and distinguish
`from eloquent correx with brain mapping.
`
`24 Complementary and Alternative Therapies 146
`Derek]. Chong ·
`Numerous patient surveys have shown an increase in the use of complementary
`and alternative therapies-they are used by up to 25% of the epileptic
`population. Diet as an altern~tive therapy fur seizures has been effective for many
`patients, while botanicals, biofeedback, and other approaches show promise but .
`have not yet been proven or standardized. Being open-minded but exercising
`caution may be the best approach for the neurologist.
`
`SECTION IV PROGNOSTIC, SOCIAL, AND BEHAVIORAL ISSUES
`
`25 Depression In Epilepsy 153
`Daniel Friedman
`Depressive symptoms are common in patients with epilepsy and occur at much
`higher rates than in the general population. Patients with epilepsy have higher
`rates of suicide as well. Identifying and treating mood disorders can improve the
`quality of life for epilepsy patients.
`.,
`
`26 Psychosis and Seizures 159
`Carl w. Bazil
`Psychosis can rarely occur in the immediate postictal period; this is usually
`transient but can result in injury. More difficult from a diagnostic standpoint may
`be postictal psychosis, as this may begin"days after a seizure.
`In cases of unusual or refractory psychosis, consideration should be given to the
`possibility of unrecognized seizures causing or exacerbating psychosis.
`
`27 Cognitive and Behavioral Issues 164
`Carl w. Bazil
`Two of the most common complaints in patients with epilepsy are mood
`problems and difficulty with cognition. Both have numerous possible causes, but
`treatment choices in patients with epilepsy should always be made with these
`in mind.
`
`CONTENTS
`
`Alii
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 13/216
`
`

`
`28 Sreep Disturbances In Epilepsy 170
`Carl w. Bazil
`Quality sleep is important for everyone but is panicularly important in patients
`with epUepsy. Sleep disruption from any cause can contribute to the intractability
`of epUepsy and can also cause drowsiness, inattention, and apparent memory
`dysfunction. Vigilance for coexisting sleep disorders is an important aspect of
`epilepsy care.
`
`29 Bone Health 176
`Derek]. Chong
`Reduced bone density has been shown to be a significant comorbidity for patients
`with epUepsy. Thus far, it seems that enzyme-inducing medications have the
`greatest risk fur causing problems with bone health. Replacing the potentially
`offending agent is likely necessary. Repletion of vitamin D through
`supplementation appears safe, though it is not known what will be the most
`effective treatments.
`
`30 Sudden Unexpected Death In Epilepsy (SUDEP) 179
`Daniel Friedman
`Patienu with epilepsy have a much higher rate of unexpected sudden death
`compared to the general population. Patients with poorly controlled epUepsy and
`frequent tonic~clonic seizures are at a panicularly high risk.
`
`31 Work, Driving, and Epilepsy 183
`Carl W. Bazil
`Safety is of primary importance in patients with epilepsy. This is particularly
`concerning with driving and in work or other activities that may place the patient
`and others at risk should a seizure occur. The risk of seizure recurrence must be
`considered on an individual basis before recommendations can be made, but
`general guidelines are also helpful in discussing this topic with patients.
`
`Appendices 189
`
`Index 201
`
`AIV
`
`CONTENTS
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 14/216
`
`

`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 15/216
`
`

`
`•
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 16/216
`
`

`
`Febrile seizures (seizures that occur with fever in the absence of known
`
`epilepsy, CNS infection, or metabolic disorder) can occur in children
`berween 6 months and 5 years of age. They are typically divided into simple
`and complex febrile seizures. Simple febrile seizures last less than 15 minutes
`and occur once within a 24-hour period. Complex febrile seizures are pro(cid:173)
`longed, recur within 24 hours, or have obvious focal features (e.g.•, clonic
`activity of one limb). A careful hisrory and physical examination is neces(cid:173)
`sary to evaluate for potentially life-threatening infections and to determine
`if the child was neurologically intact prior to the seizures and if the fever
`preceded the seizure, as mild hyperpyrexia may follow seizure activity. In
`infants less than 12 to 18 months of age, signs of meningitis may be difficult
`to appreciate and lumbar puncture should be considered to exclude CNS
`infection. In the case of simple febrile seizures, EEG and brain imaging is
`typically not warranted unless there is a history of preceding neurologic
`abnormality.
`Febrile seizures are common, with an incidence of2o/o to 5% before age 5.
`Febrile seizures tend to recur: approximately 40% of patients will have
`another febrile seizure, bur only 9% experience 3 or more days with febrile
`seizures. Age of onset is/an important factor, as infants less than 1 year of
`age have a 50% chance of recurrence, whereas the rate is only 20% in those
`with onsets at 3 years of age or older. Other predictors of recurrence include
`a family history of febrile seizures, a low fever or a short duration of fever
`prior to the seizure, or complex febrile seizures. The number of risk factors
`
`TABLE H
`
`~e,.~.~.~.~~,~.:~~~~res an~. ~.~,..Facto~~.f~.~,~~~.~~.quent Epile~;J .•
`
`Increased Risks:
`
`Age of febrile seizure
`
`Ages< 3 months and > 5 years
`
`Duration
`
`Frequency
`
`Focal Features
`
`Family history
`
`> 15 min
`
`Seizure recurrence within 24 hours
`
`Obvious (unilateral clonic activity, Todd's paresis)
`
`Afebrile seizures in parent or sibling
`
`Baseline Neurological
`status
`
`Abnormal
`
`4
`
`\'./HAT DO I DO NOW? EPILEPSY
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 17/216
`
`

`
`present increased the risk of febrile seizure recurrence: two or more factors
`predict a 30% chance, and 3 or greater risk factors purports a 60% risk.
`There is no evidence that the number of febrile seizures influences the
`risk of subsequent epilepsy. Furthermore, there is no evidence that simple
`febrile seizures lead to any measurable brain injury. The neurologic impact
`of prolonged febrile seizures and febrile starus epilepticus is unknown, but
`preliminary imaging studies show effects on hippocampal structures. This
`suggests that febrile status epilepticus, like other forms of status epilepticus,
`should be identified early and treated aggressively.
`The rare of subsequent afebrile seizures (i.e., epilepsy) following a simple
`febrile seizure is low and is likely no greater than in the general population.
`Some clinical features, such as febrile seizures before 12 months of age and
`a family history of epilepsy or febrile seizures, may suggest a genetic predis(cid:173)
`position to seizures such as the generaljzed epilepsy with febrile seizures plus
`(GEFS+) syndrome, and these patients are at a slightly higher risk of devel(cid:173)
`oping epilepsy. Patients with complex febrile seizures have a higher rate of
`subsequent epilepsy, with approximately 6% to 8% having unprovoked sei(cid:173)
`zures by age 25. If there are focal features and the seizures are repetitive or
`prolonged, the risk is much higher. Other factors that increase the risk for
`subsequent epilepsy include neurologic abnormalities prior to the seizure,
`younger age at onset, or a family history of epilepsy. Rarely, febrile seizures
`are the first manifestation of severe myoclonic epilepsy of infancy (SMEI or
`Dravet syndrome), a catastrophic epileptic encephalopathy of infancy, most
`often due to a mutation in the SCN 1A gene. This disorder typically presents
`with complex febrile seizures before age 1 in otherwise normally developing
`infants A genetic test is available and should be used tO screen these patients,
`as many with this typically sporadic genetic abnormality will experience
`developmental abnormalities in the following years.
`While the peak incidence of febrile seizures occurs between 18-24
`months of age, a large proportion of all seizures occur before age 1. Mebrile
`seizures in infancy are often due to structural, genetic (single gene), chro(cid:173)
`mosomal, or metabolic abnormalities. Sometimes, afebrile or unprovoked
`seizures have a benign course, such as in benign neonatal convulsions or
`benign infantile seizures. These epilepsy syndromes typically occur in oth(cid:173)
`erwise neurologically normal infants, spontaneously remit, and have only a
`modestly elevated risk of epilepsy later in life. Other conditions, such as
`
`1. FEBRILE SEIZUR~S AND OTHER SEIZUR~S IN INf'ANTS
`
`5
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 18/216
`
`

`
`',
`
`early infantile epileptic encephalopathy (Ohtahara syndrome), West syn(cid:173)
`drome, Dravet syndrome (discussed above), early myoclonic epilepsy, and
`myoclonic epilepsy in infancy, are associated with difficult-to-treat epilepsy
`and significant developmental delay. Because of the poor prognosis of many
`seizures presenting in infancy, it is important to emphasize the ben1gn
`nature of febrile seizures to parents, who are justifiably anxious.
`
`TREATMENT
`
`Because of the benign nature of most febrile seizures, prophylactic treatment
`with antiepileptic drugs (AEDs) is usually not recommended. While AEDs
`such as phenobarbital, primidone and valproic acid have been shown to sup~
`press future febrile seizures, they do not prevent the development of subse(cid:173)
`quent epilepsy and are often associated with neurocognitive side effects that
`typically outweigh any benefits. The use of antipyretics such as acetamino ...
`phen does not appear to prevent seizure recurrence. This suggests that a high
`temperature alone does not provoke febrile seizures and other factors, such
`as inflammatory cytokines, are the proconvulsant stimulus. Acetaminophen
`and ibuprofen are considered safe and effective antipyretics to use in these
`children, but parents should be advised they are being used primarily for'
`comfort. Current practice parameters have instead recommended acute
`abortive therapies such as rectal diazepam (0.5 mg/kg) (max 20 mg) or mida(cid:173)
`zolam administered intranasally (0.2 mglkg; divided per nostril) (max 10 mg
`total) or bucally (0.5 mg/kg)*, to limit the duration of seizures and prevent
`hospitalization. In rare patients where recurrence is frequent or caregivers are
`unable to administer abortive treatment, prophylactic treatment with an oral
`benzodiazepine (e.g. lorazepam, clonazepam) during a febrile illness or
`chronic antiepileptic treatment, typically phenobarbital, can be considered.
`This child had a complex febrile seizure because he had two seizures
`several hours apart. In addition, he has a family history of epilepsy. These '
`two factors suggest he may have a reduced seizure threshold and is at
`increased risk for developing subsequent epilepsy. At this time, no avai·lable
`treatment can reduce that risk. He also has a high risk of febrile seizure
`recurrence because of the age of onset being < 1 year of age. He should(cid:173)
`continue to be immunized as scheduled, including influenza vaccines, to
`reduce the number of chifdhood febrile illnesses. In addition, because his
`
`6
`
`WHAT DO I DO NOW? !PILEPSV
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 19/216
`
`

`
`seizures were repetitive, his parents could be instructed in the use of an
`abortive therapy to prevent seizure clusters. As with most patients, the use
`of chronic AEDs is not recommended in this case.
`*Nasal and buccal routes of midazolam administration are not US FDA
`approved.
`
`Further Reading
`Steering Committee on Quality Improvement and Management, Subcommittee on Febrile
`Seizures: clinical practice guideline for the long-term management of the child with
`simple febrile seizures. Pediatrics. 2008;121(6):128H286.
`Annegers JF, Hauser WA, Shirts SB, Kurland LT •. Factors prognostic of unprovoked seizures
`after febrile convulsions. N Eng/ J Med.1987;316(9):493-498.
`Chungath M, Shorvon s. The mortality and morbidity of febrile seizures. Nature Cfln Pract
`Neurol. 2008;4(11):61 o-621.
`Hirtz D, Berg A, Bettis D, et al. Practice parameter: treatment of the child with a first
`unprovoked sei:wre: Report of the Quality Standards Subcommittee of the American
`Academy of Neurology and the Practice Committee of the Child Neurology Society.
`Neurology. 2003;60(2):166-175.
`Millichap JJ, Koh S, Laux LC, Nordli DR. Child neurology: Dravet syndrome: when to
`suspect the diagnosis. Neurology. 2009;73(13):e59-62.
`
`1. FEBRILE SEIZURES AND OTHER SEIZURES IN INFANT$
`
`]
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 20/216
`
`

`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 21/216
`
`

`
`•
`
`the night. He has associated issues with depression,
`anxiety, headaches, and difficulty concentrating. The rest
`of his history and review of systems is negative except
`for non-migrainous headaches over the frontal convexity.
`A first cousin on his mother•s side had a diagnosis of
`benign rolandic epilepsy.
`His mother is worried about the continued seizures
`and is wondering whether the diagnosis and treatment
`plans are correct.
`
`2. BENIGN/IDIOPATHIC PARTIAL EPILEPSIES UP£. OF CHILDHOOD
`
`9
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 22/216
`
`

`
`enign childhood epilepsy with centrotemporal spikes (BECTS) is
`often referred to as BECfS or simply benign rolandic epilepsy. It is the
`most common idiopathic partial epilepsy (IPE). Similar to his case, seizures
`classically occur shortly after falling asleep or just R,tior to awakening,
`though any pattern of sleep-awake or awake-only seizures can occur. The
`seizures during wakefulness are exclusively simple partial events, often with
`unilateral paresthesias of the oral mucosal surfaces; unilateral clonic or tonic
`activity involving the face, lips, and tongue; dysarthria; and drooling.
`Stiffness of the jaw or tongue and a choking sensation are common. Unlike
`this case, patients typically recall the wakeful part of the seizures and
`are rarely confused during them. Seizure duration is typically seconds to
`minutes.
`Typical n_ocrurnal seizure activity includes:
`
`1. Brief hemifacial seizures with speech arrest and drooling while still
`conscious.
`2. Hemifacial seizures with loss of awareness, gurgling, or grunting
`that may progress to vomiting.
`3. Secondary generalized tonic-clonic seizures.
`
`, PostJctal Todd's paresis may occur; this would be a clue to a partial origin.
`The typical age of onset is 7 to 8 years but varies widely from age 3 to 13.
`Younger patients tend to present with hemiconvulsions.
`Rarely, status epilepticus can occur. Other variants may occur, such
`as partial motor seizures changing lateralization) paresthesias, jerking of a
`single limb, abdominal pain, blindness, and vertigo.
`The "benign" term is evidenced by over 99% of cases remitting by age 18
`in case series of about 400 patients. Many practitioners begin weaning
`off medication around age 16 if there have been no seizures in the past
`6 months. It is notable that a small subset of BECTS patients who develop
`atonic, atypical absence or myoclonic seizures, termed "pseudo-Lennox,
`syndrome, may have cognitive losses despite eventual seizure remission.
`' BECTS can occur with a known structural abnormality, but seizures in
`these cases also typically remit. In the patient presented above there was one
`unusual seizure, with symptoms lasting over a day. If his seizures were not
`responding to medication, it would be reasonable to obtain an MRI of the
`head. Otherwise, MRI scanning of the head is considered unnecessary in
`
`tO
`
`WHAT DO I DO NOW? EPILEPSY
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 23/216
`
`

`
`..
`
`patients with a normal neurological examination and typical seizures and
`EEG findings. The classic EEG finding is the presence of large-amplitude
`but often simply configured spike or sharp waves with large after-going slow
`waves, with a dipole: the negativity is central and positivity is seen frontally
`(Fig. 2.1, 2.2). The epileptiform discharges may be unilateral or bilateral,
`either synchronous or independent. They may occur during wakefulness
`but become activated by non-REM sleep and drowsy states. If the diagnosis is
`in doubt, repeating the EEG with a sleep state can be helpful, although it needs
`to be interpreted in the clinical context. It appears that only 10% of children
`with these rolandic spikes actually have the clinical seizures. The EEG may
`evolve in terms of location and may even show atypical spike locations.
`However, finding generalized discharges, spike-wave runs, or other types of
`partial seizures would significantly change the diagnosis and thus prognosis.
`There is a familial component, sometimes with an autosomal dominant
`inheritance. Linkage analysis has implicated chromosome 15q 14, though
`BECfS . appears to be heterogeneous. Many siblings show the same
`centro-temporal spikes on EEG, though they may nor necessarily have the
`
`~~ .....,
`
`~---... ~~,..,..,..~~
`
`fpl:-fll.,.. .................... ~~~ \...r"'-"'\...-..___.,..~~----~ ........... - ................. ~ ... ~-""' .... ~.~
`n.a,~~--J-....,5--
`.._,_~-...~~~ .... --~........_ .......... ~-.............. ..;,.~.-~
`,....._..,
`-
`tp.Pf/'~--~-,._ -~J-"'-
`Pl-atrv--,._~.,-,.._, ~~~~-~-_,_r..._,...;
`..., ________________ ~---~__,.,~...,....____ • ·~_.,._,-~---/'<'~""""~ .
`... ,._-,t---.....'"----'""'--..,.-_~----..--1\
`~---...~~Y"t-"•"""-"r"-
`/
`•
`......__,
`..... ~,---·~ ... -~--- .... ------... ~~--<V-
`t4:~...-~~-~JIM...._,I"-"V>-"\-"-"'~
`'
`.... ~~.,....,.---......-...-.....,_v-v---...;.,,/''"""
`••·tJP'v-'""'~-~""'-~ ......... ~~~ .... ~~---..,.,._..,..r-.,.~___....---...
`C. .. Pf'l.r .. A,.._............,, __ ,~- ..... ~--_x-........ ~"f\.v,~-...fwr..,~ .... ..........n.... ..... ,__.,.....~"'Y'r--.... Y'II...J~ .. ~~, ...
`k\
`'-'<fA.t~vl'-1!'•-v..JI-,.
`'~4W. f-..l'~tJVJ'af""
`;I'
`"!1'1-..tv .... vv~· ......... -.......-.. ... --..
`~~~....._~ ...... ~-vv\·w·"\'fi'¢>f>t· ~
`,!,.,. ----1 .. "·----L-._ .... L-,_ ..... L· .. -L .. --.. -~L· .. -.. -L.,_ .. ~i-'-··-·1-, .... .J ........... L.· ...... J ......... J .... _ .. .L-· ..... J ...... .
`1lillf]ihll AJI!JlltCII 1 g.~
`
`~~... .~..-~~~~.....--.,..v-fot,.._,~.,._.
`
`·-
`
`FIGURE 2 8 1 Epileptiform discharges typical of benign rolandlc epilepsy or BECTS. The
`discharges are lateraltzed with a broad field over left <arrows> temporal (T7) and central
`postero-central (P3) and the right (arrowheads) temporal (TB) or central (C4·P4) regions.
`Note the relatively simple configuration to the majority of the discharges. In this example.
`the spike discharges preceded the onset of one of the patient's typical nocturnal
`hemlconvulsive seizures from sleep arising from C4·TB (*).
`
`2. BENtGN/IDIOPATH\C PARTIAL EPILEPSIES OPE} OY' CHILDHOOD
`
`11
`
`
`
`Argentum Pharm. v. Research Corp. Techs., IPR2016-00204
`RCT EX. 2077 - 24/216
`
`

`
`v
`
`FJS;..IWO 1
`F.C ·£1¥8 17
`C4 - kfil17 .................. --...~
`
`P.C-~17·--~~~~~~~-~~~
`02-~17 v
`
`F7. A¥g 17
`
`T1. AYg 17 .... ,...~---,...
`
`P7-~ 17
`
`FO - I\VII f7
`TB- A¥g 17
`
`P8- AlJg f7
`
`Fz • ... A9J 1
`C2- Ava 17
`
`Pz- AlJg 1
`
`FIGURE 2·2 The first spike In Figure 2.1 displayed In Common Average Referential montage,
`highlighting a typical dipole: upwards negativity over P3, T7, and P7 (arrows) and downwards
`positivity over Fp1, F3, and Fz. The dipole Is classically described as being obvious on long
`blploar montage, though It often requires closer review, as In this case.
`
`clinical seizures. In patients with unusual presentations, the presence of
`similar centro-temporal spikes in their siblings would be more supportive of
`BECTS. Many believe the pathophysiology to be due to abnormal brain
`maturation, with changes in synapses (pruning or development of more
`inhibitory connections) or with changes in the electrical characteristics of
`ion channels with time. There is an increased rate of migraine and other
`headaches with BECTS.
`AED treatment does not improve. the chance of remission, and there
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket